✦ LIBER ✦

Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir

✍ Scribed by Barbara Vergani; Mirko Lo Cicero; Ottavia Vigano’; Francesca Sirianni; Stefania Ferramosca; Paola Vitiello; Paola Di Vincenzo; Maria Pia De Pasquale; Massimo Galli; Stefano Rusconi

Book ID: 116631269
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 214 KB
Volume: 41
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2007.10.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of the combination ralt

Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients

✍ Jansen, A; Colbers, EPH; van der Ven, AJAM; Richter, C; Rockstroh, JK; Wasmuth, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Atypical pharmacokinetics of atazanavir

Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient

✍ Dario Cattaneo; Paola Meraviglia; Valeria Cozzi; Sara Baldelli; Greta Milani; Em 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Application of HIV-1 genotypic-resistanc

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients

✍ Bernhard Zöllner; Heinz-Hubert Feucht; Lutwin Weitner; Axel Adam; Matthias Schrö 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 107 KB

External Validation of the Bilirubin–Ata

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

✍ Dinko Rekić, Daniel Röshammar, Martin Bergstrand, Joel Tarning… 📂 Article 📅 2012 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 378 KB

Sequence analysis of the HIV-1 protease

Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART

✍ H Gehringer; J.R Bogner; F.D Goebel; H Nitschko; K von der Helm 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB

The Protease Inhibitor Transfer Study (P

The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load

✍ M Bickel; V Rickerts; C Stephan; V Jacobi; C Rottmann; B Dauer; A Carlebach; A T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB